- Home
- FHTX vs LFVN Comparison
FHTX vs LFVN Comparison
Compare FHTX & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- LFVN
- Stock Information
- Founded
- FHTX 2015
- LFVN N/A
- Country
- FHTX United States
- LFVN United States
- Employees
- FHTX N/A
- LFVN N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- FHTX Health Care
- LFVN Health Care
- Exchange
- FHTX Nasdaq
- LFVN Nasdaq
- Market Cap
- FHTX 237.4M
- LFVN 269.4M
- IPO Year
- FHTX 2020
- LFVN N/A
- Fundamental
- Price
- FHTX $4.10
- LFVN $21.56
- Analyst Decision
- FHTX Strong Buy
- LFVN Strong Buy
- Analyst Count
- FHTX 6
- LFVN 2
- Target Price
- FHTX $13.17
- LFVN $30.50
- AVG Volume (30 Days)
- FHTX 110.9K
- LFVN 263.4K
- Earning Date
- FHTX 03-06-2025
- LFVN 02-05-2025
- Dividend Yield
- FHTX N/A
- LFVN 0.69%
- EPS Growth
- FHTX N/A
- LFVN 59.77
- EPS
- FHTX N/A
- LFVN 0.32
- Revenue
- FHTX $25,515,000.00
- LFVN $196,014,000.00
- Revenue This Year
- FHTX N/A
- LFVN $21.53
- Revenue Next Year
- FHTX $7.37
- LFVN $8.48
- P/E Ratio
- FHTX N/A
- LFVN $72.86
- Revenue Growth
- FHTX N/A
- LFVN N/A
- 52 Week Low
- FHTX $2.81
- LFVN $5.22
- 52 Week High
- FHTX $10.25
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- FHTX 38.20
- LFVN 58.37
- Support Level
- FHTX $3.89
- LFVN $19.44
- Resistance Level
- FHTX $4.64
- LFVN $24.06
- Average True Range (ATR)
- FHTX 0.34
- LFVN 1.88
- MACD
- FHTX 0.07
- LFVN -0.32
- Stochastic Oscillator
- FHTX 30.77
- LFVN 59.38
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.